Tenaya Therapeutics

Developer of regenerative and gene therapeutics for heart failure

placeSan Francisco, California, United States calendar_todayFounded 2016 groups141 employees language tenayatherapeutics.com

Registered entities

Innovation

40 patent families (10 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 6,005 times.

YearFilings
20202
20219
202213
202316
202419
202525
20268

Social engagement

Social engagement: 18.6K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include RTW Investments, RA Capital Management, Fidelity Investments, Casdin Capital; 1 has since exited.

Investor typeCountShare
Venture capital667%
Other / undisclosed333%

Recent activity

29 Jun 2026
Leadership hire
Chief Financial Officer
3 Jun 2026
Event
webcast conference call at 8:00 a.m. ET
29 May 2026
Event
Jefferies Global Healthcare Conference
Coming soon